JW (Cayman) Therapeutics Co. Ltd (HKG:2126)

HKG:2126 Statistics

Total Valuation

HKG:2126 has a market cap or net worth of HKD 916.74 million. The enterprise value is 615.87 million.

Market Cap	916.74M
Enterprise Value	615.87M

Important Dates

The next estimated earnings date is Wednesday, March 25, 2026.

Earnings Date	Mar 25, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2126 has 405.64 million shares outstanding. The number of shares has increased by 0.58% in one year.

Current Share Class	405.64M
Shares Outstanding	405.64M
Shares Change (YoY)	+0.58%
Shares Change (QoQ)	+0.35%
Owned by Insiders (%)	3.99%
Owned by Institutions (%)	0.35%
Float	319.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.71
PB Ratio	0.92
P/TBV Ratio	1.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.91
EV / Sales	3.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.77

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.41.

Current Ratio	1.59
Quick Ratio	1.44
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	-1.84
Interest Coverage	-26.79

Financial Efficiency

Return on equity (ROE) is -51.67% and return on invested capital (ROIC) is -13.22%.

Return on Equity (ROE)	-51.67%
Return on Assets (ROA)	-12.23%
Return on Invested Capital (ROIC)	-13.22%
Return on Capital Employed (ROCE)	-35.04%
Weighted Average Cost of Capital (WACC)	11.35%
Revenue Per Employee	667,034
Profits Per Employee	-2.32M
Employee Count	292
Asset Turnover	0.10
Inventory Turnover	1.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.14% in the last 52 weeks. The beta is 2.00, so HKG:2126's price volatility has been higher than the market average.

Beta (5Y)	2.00
52-Week Price Change	+29.14%
50-Day Moving Average	2.68
200-Day Moving Average	3.37
Relative Strength Index (RSI)	36.91
Average Volume (20 Days)	1,077,149

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2126 had revenue of HKD 194.77 million and -676.78 million in losses. Loss per share was -1.63.

Revenue	194.77M
Gross Profit	108.14M
Operating Income	-364.41M
Pretax Income	-676.78M
Net Income	-676.78M
EBITDA	-294.53M
EBIT	-364.41M
Loss Per Share	-1.63

Balance Sheet

The company has 709.01 million in cash and 408.13 million in debt, with a net cash position of 300.88 million or 0.74 per share.

Cash & Cash Equivalents	709.01M
Total Debt	408.13M
Net Cash	300.88M
Net Cash Per Share	0.74
Equity (Book Value)	995.63M
Book Value Per Share	2.46
Working Capital	303.20M

Cash Flow

In the last 12 months, operating cash flow was -219.30 million and capital expenditures -2.85 million, giving a free cash flow of -222.15 million.

Operating Cash Flow	-219.30M
Capital Expenditures	-2.85M
Free Cash Flow	-222.15M
FCF Per Share	-0.55

Margins

Gross Margin	55.52%
Operating Margin	-187.09%
Pretax Margin	-347.47%
Profit Margin	n/a
EBITDA Margin	-151.22%
EBIT Margin	-187.09%
FCF Margin	n/a

Dividends & Yields

HKG:2126 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.58%
Shareholder Yield	-0.58%
Earnings Yield	-73.82%
FCF Yield	-24.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2126 has an Altman Z-Score of -5.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.43
Piotroski F-Score	4